Fox Run Management L.L.C. Acquires New Position in Humana Inc. $HUM

Key Points

• Fox Run Management L.L.C. has acquired a new stake in Humana Inc. by purchasing 4,049 shares valued at approximately $1,071,000 in the first quarter of the year.
• Humana reported earnings per share of $6.27 for the last quarter, missing the consensus estimate, but had a 9.6% year-over-year revenue increase to $32.39 billion.
• Analysts have given Humana an average rating of "Hold" with a price target around $281.45, reflecting cautious sentiment surrounding the company’s stock performance.

Fox Run Management L.L.C. bought a new position in Humana Inc. (NYSE:HUM - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 4,049 shares of the insurance provider's stock, valued at approximately $1,071,000.

Several other large investors have also bought and sold shares of HUM. Cary Street Partners Investment Advisory LLC grew its stake in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after acquiring an additional 46 shares during the period. Riverview Trust Co bought a new stake in shares of Humana in the first quarter worth approximately $34,000. Garde Capital Inc. bought a new stake in shares of Humana in the first quarter worth approximately $36,000. Zions Bancorporation National Association UT bought a new stake in shares of Humana in the first quarter worth approximately $37,000. Finally, Transce3nd LLC bought a new stake in shares of Humana in the fourth quarter worth approximately $38,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on HUM. Cantor Fitzgerald reiterated a "neutral" rating and issued a $290.00 price target on shares of Humana in a research note on Thursday, May 1st. Truist Financial reduced their price target on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Morgan Stanley cut their target price on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research report on Thursday, July 31st. Wall Street Zen lowered shares of Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Finally, Robert W. Baird cut their target price on shares of Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Seven investment analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company's stock. According to MarketBeat, Humana currently has a consensus rating of "Hold" and an average target price of $281.43.

Humana Trading Up 0.3%

HUM stock traded up $0.8280 during mid-day trading on Tuesday, reaching $288.0180. 970,501 shares of the stock traded hands, compared to its average volume of 1,728,735. The business has a 50-day moving average price of $243.80 and a two-hundred day moving average price of $253.20. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The stock has a market capitalization of $34.64 billion, a PE ratio of 22.12, a PEG ratio of 1.68 and a beta of 0.44. Humana Inc. has a one year low of $206.87 and a one year high of $382.72.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.